Deborah J. Wexler, MD, MSc, and colleagues reviewed recent shifts in diabetes care, such as SGLT2i and GLP-1 RA medications. In recognition of Diabetes Awareness Month, the American Red Cross will offer blood donors free HbA1c testing this November. An article in Current Opinion in Endocrinology, Diabetes and Obesity discussed pharmacologic agents for hypercortisolism. An article in Reviews in Endocrine and Metabolic Disorders provided guidance for safe exercise prescriptions for weight ... Test your knowledge on the prevalence, diagnosis, genetics, and main causes of acromegaly in this quick quiz! Incorporating metformin in burn metabolic care may help control hyperglycemia and broader metabolic dysfunction. Rajesh K. Jain, MD, shares how race and ethnicity impact osteoporosis epidemiology and treatment in the United States. Biochemical tests that assess cortisol have limited diagnostic accuracy, and their performance can vary by patient. Rates of transient ischemic attack, mitral valve stenosis, and heart failure declined after parathyroidectomy for pHPT. Autoimmune thyroid disease can cause disturbances in cognition, memory, and mood, a growing body of evidence suggests. Over the course of months, a young woman noticed subtle yet persistent changes in her body and appearance. A weight loss intervention led to reduced CMP severity tied to improved diet quality, independent of changes in adiposity. An article in Reviews in Endocrine and Metabolic Disorders shared how to communicate with patients during weight loss. Newer tools like optical coherence tomography and electroretinography improve detection of diabetic retinopathy progression. A study suggests continuous glucose monitoring improves patients' capability and motivation regarding their diabetes care. Test your acromegaly expertise—features, treatment facts, and complications every clinician should know. Researchers found gender-affirming hormone therapy had potential effects on cardiac repolarization in transgender patients. Researchers found novel inflammatory markers positively correlated with insulin resistance in patients with type 2 diabetes. Patients had a much higher risk of recurrence if their calcium level was 10 mg/mL or greater six months after surgery. Higher IMAT mid-thigh, as opposed to the abdominal region, may better predict cardiometabolic risk in obesity and overweight.